111, Inc., co-founded by Gang Yu and Junling Liu in 2010, is a leading digital and mobile healthcare platform in China. Through the T2B2C business model, by leveraging technology to enable businesses better serve customers, 111, Inc. is devoted to digitally connecting patients with drugs and healthcare services, to build the largest healthcare platform in China.
Relying on advantages in Internet technology, smart supply chain, omni-channel commercialization, cloud-based solutions, and other aspects, 111, Inc. integrates online and offline retail platforms and terminals, establishes a healthcare ecosystem, and empowers doctors, pharmacies, hospitals, pharmaceutical companies, drug distributors, insurance companies and other enterprises. 111, Inc. aims to deliver the best and comprehensive healthcare solutions to Chinese people.
The main business lines of 111, Inc. include: 1 Drugstore (online B2C pharmacy platform), 1 Clinic (Internet hospital) and 1 Drug Mall (online B2B pharmacy platform). Through innovative technology-enabled models, fully realizing the integrated development of B and C, online and offline, self-operating and platform, and medical + pharmaceutical + insurance. On September 12, 2018, 111, Inc. was listed on NASDAQ with ticker YI. It is the first Internet health company from China listed in the US stock exchange.
Location of Key Operations
Deloitte Touche Tohmatsu CPA LLP
IPO (September 12, 2018)
6 Fulfillment Centers: Guangzhou, Kunshan, Tianjin, Chongqing, Wuhan, Fuzhou)
September 17, 2021: 111, Inc. Announces Participation in the Cantor Virtual Global Healthcare Conference - Sep 17, 2021
September 7, 2021: 111, Inc. Announces $10 Million Share Repurchase Program
August 30, 2021: ir.111.com.cn/2021-08-27-111,-Inc-Announces-Second-Quarter-2021-Unaudited-Financial-Results
August 16, 2021: 111, Inc. Deepens Partnership with Bayer Healthcare - Aug 16, 2021
May 19, 2021: 111, Inc. Announces First Quarter 2021 Unaudited Financial Results - May 19, 2021
April 21, 2021: 111 to Announce First Quarter 2021 Unaudited Financial Results on May 19, 2021 - Conference Call to Follow
March 25, 2021: 111 Signs Strategic Cooperation Agreement with Jianming Pharmaceutical to Develop Chronic Disease Management Platform
March 18, 2021: 111 Inc (YI) Q4 2020 Earnings Call Transcript
March 17, 2021: 111, Inc. Announces Fourth Quarter and Fiscal Year 2020 Unaudited Financial Results
March 17, 2021: 111, Inc. Enters into First-Ever Strategic Partnership with BeiGene
March 16, 2021: 111, Inc. Achieves Full Distribution Coverage Across Mainland China with the Opening of Two Key Fulfillment Centers
February 25, 2021: 111 to Announce Fourth Quarter and Fiscal Year 2020 Unaudited Financial Results on March 18, 2021
February 5, 2021: 111, Inc. Signs Strategic Cooperation Agreement with Jilin Baiyi Doctor Group to Create & Deliver New Models for Internet Medical Services